Nuclear Medicine and Biology
Volume 37, Issue 8 , Pages 949-955 , November 2010

177Lu labeling of Herceptin and preclinical validation as a new radiopharmaceutical for radioimmunotherapy of breast cancer

  • Samira Rasaneh

      Affiliations

    • Department of Medical Physics, Faculty of Medical Sciences, Tarbiat Modares University, P.O. Box 14115-331, Tehran, Iran
    • ,
  • Hossein Rajabi

      Affiliations

    • Department of Medical Physics, Faculty of Medical Sciences, Tarbiat Modares University, P.O. Box 14115-331, Tehran, Iran
    • Corresponding Author InformationCorresponding author. Tel.: +98 21 82883894; fax: +98 21 88006544.
    • ,
  • Mohammad Hossein Babaei

      Affiliations

    • Department of Radioisotope, Nuclear Science and Technology Research Institute, 14115-331 Tehran, Iran
    • ,
  • Fariba Johari Daha

      Affiliations

    • Department of Radioisotope, Nuclear Science and Technology Research Institute, 14115-331 Tehran, Iran

Received 8 March 2010 ,Revised 30 May 2010 ,Accepted 1 July 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0969-8051(10)00319-7

doi: 10.1016/j.nucmedbio.2010.07.001

Nuclear Medicine and Biology
Volume 37, Issue 8 , Pages 949-955 , November 2010

Article Tools

* Image Usage & Resolution